Synthetic Biology

Can Scientists Create Life From Non-Living Chemicals?
Biotech & Bioprocessing Can Scientists Create Life From Non-Living Chemicals?

The boundaries between organic existence and laboratory-engineered chemistry have blurred significantly following a landmark achievement where researchers successfully assembled a functional cell from a collection of entirely non-living molecules. Led by Kate Adamala at the University of Minnesota,

Can Humans Unlock the Dormant Ability to Regrow Limbs?
Biotech & Bioprocessing Can Humans Unlock the Dormant Ability to Regrow Limbs?

The prospect of humans regaining the ability to regenerate lost limbs has long been relegated to the realm of high-concept science fiction, but current research suggests that this biological superpower is merely dormant within the human genome. Recent breakthroughs at the Texas A&M University

Generative Food Design – Review
Tech & Innovation Generative Food Design – Review

When a machine begins to deconstruct the chemical architecture of a hamburger, it does not see a meal but rather a high-dimensional optimization problem waiting to be solved. This shift represents a significant advancement in the food technology and culinary engineering sectors, where the

NICE Platform Delivers Megabase Synthetic DNA into Embryos
Biotech & Bioprocessing NICE Platform Delivers Megabase Synthetic DNA into Embryos

The realization of complex genetic engineering has long been tethered to the physical constraints of DNA stability, yet the emergence of the NICE platform has finally unlocked the capacity to deliver megabase-scale synthetic constructs into mammalian embryos with unprecedented reliability. Nucleus

How Is Bioprocessing Tech Reshaping Modern Industry?
Management & Regulatory How Is Bioprocessing Tech Reshaping Modern Industry?

The evolution of bioprocessing technology has moved far beyond the sterile confines of pharmaceutical laboratories where it once exclusively served the production of high-value medicine. Today, the same sophisticated engineering principles used to manufacture monoclonal antibodies are being rapidly

How Can AI and CRISPR Unlock Living Drugs for Solid Tumors?
Research & Development How Can AI and CRISPR Unlock Living Drugs for Solid Tumors?

The recent awarding of the European Research Council Advanced Grant to Christoph Bock represents a pivotal shift in the trajectory of modern oncology by prioritizing the development of sophisticated living drugs. These therapies, particularly chimeric antigen receptor (CAR) T cells, have already

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later